These clinical tissue data strengthen our presumption that USP4 controls the CypA protein level in patients through deubiquitination, which may indicate that USP4 overexpression, which subsequently regulates CypA protein levels, is a hazard parameter for poor prognosis of HCC patients. The gene discussed is USP4; the disease is hepatocellular carcinoma.